Glucose Tolerance Test Market, By Product Type, By Disease Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
Glucose tolerance test market size was valued at USD 26,920.43 Million in 2023, expanding at a CAGR of 6.60% from 2024 to 2032.
A glucose tolerance test (GTT) is a diagnostic tool used to evaluate the body's response to sugar intake, primarily for diagnosing diabetes. It includes an oral glucose tolerance test (OGTT), where blood glucose levels are measured before and after consuming a glucose solution. High glucose levels may indicate impaired sugar absorption by body cells. A simpler version, the glucose challenge test, involves a single blood test following glucose intake.
Glucose Tolerance Test Market- Market Dynamics
Increasing rate of diabetes worldwide to propel market demand
The growing prevalence of diabetes among people across the globe is the major factor driving the growth of the global glucose tolerance test market. For instance, the global incidence of diabetes is expected to rise to 783 million by 2045, up from 537 million in 2021. Besides, increasing awareness of diabetes mellitus in densely populated regions, combined with significant investments in the design and development of large-scale diagnostic solutions, is expected to fuel market growth. However, high costs and restricted access to medical services in underdeveloped regions may hamper the market growth. On the contrary, the integration of deep learning and robotics in the diagnostic industry and increased government funding for research and development in diabetes therapeutics & diagnostics are predicted to provide massive growth opportunities for the market during the forecast period.
Glucose Tolerance Test Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.60% over the forecast period (2024-2032)
Based on product type segmentation, blood glucose test kit was predicted to show maximum market share in the year 2023
Based on disease indication segmentation, diabetes hypoglycemia was the leading segment in 2023
On the basis of region, the North America glucose tolerance test market was the leading revenue generator in 2023
Glucose Tolerance Test Market- Segmentation Analysis:
The Global Glucose Tolerance Test Market is segmented on the basis of Product Type, Disease Indication, End User, and Region.
The market is divided into four categories based on product type: blood glucose testing kit, smart sensors, meters, and others. The blood glucose testing kit sector dominates the market. Advancements in smart sensor technology and seamless IoT connectivity are driving the market growth.
The market is divided into two categories based on end user: homecare settings, hospitals & clinics, diagnostic centers, and others. The hospitals & clinics sector dominates the market and is likely to maintain its dominance during the forecast period. This is mainly due to the high patient volume they handle and the availability of advanced diagnostic tools for accurate and efficient glucose tolerance testing.
Glucose Tolerance Test Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Glucose Tolerance Test Market- Competitive Landscape:
The market is propelled by growing awareness and efforts for early diabetes detection. Companies are prioritizing strategic collaborations to enhance research and develop advanced diagnostic solutions. To stay competitive, players are investing in cutting-edge technologies, like digital health integration, for better glucose monitoring. Additionally, expanding global presence through mergers and acquisitions is a key focus, as it helps diversify product lines and reach untapped markets, boosting their overall competitiveness and market influence.
Recent Developments:
In August 2024, DirectSens has introduced the XpressGT RUO kit for diagnosing conditions like Gestational Diabetes, Endometriosis, Insulin Resistance, and Liver Disease. Compatible with standard clinical analyzers, XpressGT provides results in just 8 minutes, measuring 2-hydroxybutyrate (2-HB) levels in venous blood, which, when elevated, indicate potential endocrine and metabolic disorders.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GLUCOSE TOLERANCE TEST MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Thermo Fisher Scientific Inc.
NIPRO
Medtronic
Thermo Fisher Scientific Inc.
NIPRO
Medtronic
Trividia Health, Inc.
Healius Limited
Dexcom, Inc.
Penlan Healthcare Ltd.
Johnson & Johnson Services, Inc.
Quest Diagnostics Incorporated
Abbott
Laboratory Corporation of America Holdings
Cleveland HeartLab, Inc.
ARUP Laboratories
Merck KGaA
Ascensia Diabetes Care Holdings AG
Bayer AG
E-Zlab Health Services
LifeScan IP Holdings, LLC
F. Hoffman-La Roche Ltd.
Sanofi
Others
GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
Blood Glucose Testing Kit
Smart Sensors
Test Slips
Meters
Others
GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032
Diabetes Hypoglycemia
Reactive Hypoglycemia
Gestational Diabetes
Others
GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Homecare Settings
Hospitals & Clinics
Diagnostic Centers
Others
GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. Glucose Tolerance Test Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Glucose Tolerance Test Market Snippet by Product Type
2.1.2. Glucose Tolerance Test Market Snippet by Disease Indication
2.1.3. Glucose Tolerance Test Market Snippet by End User
2.1.4. Glucose Tolerance Test Market Snippet by Country
2.1.5. Glucose Tolerance Test Market Snippet by Region
2.2. Competitive Insights
3. Glucose Tolerance Test Key Market Trends
3.1. Glucose Tolerance Test Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Glucose Tolerance Test Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Glucose Tolerance Test Market Opportunities
3.4. Glucose Tolerance Test Market Future Trends
4. Glucose Tolerance Test Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Glucose Tolerance Test Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Glucose Tolerance Test Market Landscape
6.1. Glucose Tolerance Test Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. Glucose Tolerance Test Market - By Product Type